Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megmilk Snow Brand Co LtdfiledCriticalMegmilk Snow Brand Co Ltd
Priority to MYPI2015700285ApriorityCriticalpatent/MY167429A/en
Publication of MY167429ApublicationCriticalpatent/MY167429A/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Dairy Products
(AREA)
Abstract
THE PRESENT INVENTION ADDRESSES THE PROBLEM OF PROVIDING A SAFE AND NOVEL CHEESE PRODUCT WHICH IS USEFUL IN THE PREVENTION AND TREATMENT OF VARIOUS BONE DISORDERS SUCH AS OSTEOPOROSIS, BONE FRACTURES, RHEUMATISM, AND ARTHRITIS WHEN TAKEN ON A DAILY BASIS. A CHEESE PRODUCT CONTAINING 6.5 TO 160 MG/100 G OF ANGIOGENIN AND/OR AN ANGIOGENIN DEGRADATION PRODUCT, AND CYSTATIN AND/OR A CYSTATIN DEGRADATION PRODUCT AT A MASS RATIO OF 0.02 TO 1.6 RELATIVE TO THE ANGIOGENIN AND/OR ANGIOGENIN DEGRADATION PRODUCT. IT IS POSSIBLE TO STRENGTHEN BONES AND TO PREVENT AND TREAT VARIOUS BONE DISORDERS SUCH AS OSTEOPOROSIS, BONE FRACTURES, RHEUMATISM, AND ARTHRITIS BY TAKING SAID CHEESE PRODUCT.
MYPI2015700285A2012-07-312012-07-31Novel cheese and method for producing the same
MY167429A
(en)